Skip to content

I-gel supra-glottic airway device use in laparoscopic surgery

To determine the feasibility and safety of using I-gel supra-glottic airway device for low-flow anesthesia for laparoscopic surgery - igel

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/04/006811
Enrollment
50
Registered
2016-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cases for laparoscopic surgeries up to 2 hours duration

Interventions

Intervention1: Igel supraglottic airway: Airway will be secured by an appropriate size I-gel following administration of a non-depolarizing muscle relaxant. Control Intervention1: Endotracheal tube tr

Sponsors

Saket City Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age >18years 2.Elective Laparoscopic abdominal surgery with up to 2 hours duration anesthesia delivery. 3.ASA 1-3

Exclusion criteria

Exclusion criteria: 1. Patients undergoing a concomitant procedure. 2. Pulmonary disease and ASA 4. 3. Hypersensitivity to one or more medications. 4. Previous thoracic surgeries. 5. Anticipated difficult airway.

Design outcomes

Secondary

MeasureTime frame
â?¢To determine safety of use of low flow technique in terms of oxygen saturation. â?¢To evaluate the ease of placing the oro/naso gastric tube â?¢To determine the incidence of adverse effects of the two devices Timepoint: The parameters will be monitored and recorded every minute along with reduction of flows till 400 ml/min and thereafter every 15 min till 2 hours after which the study will be terminated.

Primary

MeasureTime frame
: To determine the lowest fresh gas flow delivery at which there is no clinical leak as compared to an endotracheal tube, which is considered as the gold standardTimepoint: The parameters will be monitored and recorded every minute along with reduction of flows till 400 ml/min and thereafter every 15 min till 2 hours after which the study will be terminated.

Countries

India

Contacts

Public ContactMukul Chandra Kapoor

Saket City Hospital

mukulanjali@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026